# The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

> **NCT06282809** · NA · RECRUITING · sponsor: **HistoSonics, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Pancreatic Cancer
- Tumor of Pancreas

## Interventions

- **DEVICE:** HistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsy

## Key facts

- **NCT ID:** NCT06282809
- **Lead sponsor:** HistoSonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2026-08
- **Final completion:** 2027-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282809, "The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06282809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*